Wave Life Sciences WVE Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's accrued expenses and other liabilities?
- Wave Life Sciences (WVE) reported accrued expenses and other liabilities of $13.04M in Q1 2026.
- How has Wave Life Sciences's accrued expenses and other liabilities changed year-over-year?
- Wave Life Sciences's accrued expenses and other liabilities increased by 66.9% year-over-year, from $7.81M to $13.04M.
- What is the long-term trend for Wave Life Sciences's accrued expenses and other liabilities?
- Over 5 years (2020 to 2025), Wave Life Sciences's accrued expenses and other liabilities has grown at a 17.3% compound annual growth rate (CAGR), from $11.97M to $26.56M.